Urology Doctors in American Fork, UT Accepting Medicare

4 Urology doctors found. Showing 1 - 4

Daniel Vernon Cahoon, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1159 E 200 N Ste 300, American Fork, UT 84003 Phone: 801-965-3600

Dr. Stewart T Landau, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1159 E 200 N Ste 300, American Fork, UT 84003 Phone: 801-965-3600

Dr. Sean Jay Henderson, D.O., F.A.C.O.S. Urology Medicare: Accepting Medicare Assignments Practice Location: 1159 E 200 N Ste 300, American Fork, UT 84003 Phone: 801-965-3600

Dr. Ronald Jay Saunders, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1159 E 200 N, American Fork, UT 84003 Phone: 801-756-7609    Fax: 801-756-6834

News Archive

Cognitive training can reduce depression, improve brain health in TBI patients

New research from the Center for BrainHealth at The University of Texas at Dallas shows that certain cognitive training exercises can help reduce depression and improve brain health in individuals years after they have suffered a traumatic brain injury.

Entrada's technology and services to be integrated into Ingenious Med platform

Today Ingenious Med, provider of the nation's leading patient encounter platform, and Entrada, a leading provider of EHR-integrated, provider productivity solutions, announced a strategic partnership to seamlessly integrate Entrada's technology and services into the Ingenious Med platform, available soon to Ingenious Med's 25,000-plus health provider client base.

BioTime receives ISO 13485:2003 certification for development of BioTime HyStem hydrogels

BioTime, Inc. today announced that it has received ISO 13485:2003 certification from BSI (British Standards Institution) for design, development, manufacture, and distribution of BioTime HyStem® hydrogels for cell delivery applications.

Researchers develop evaluation tool to help guide asymptomatic pancreatic cyst treatment

As a result of improved imaging technology, pancreatic cysts are increasingly diagnosed in asymptomatic individuals who undergo scans for other reasons. And while most of these cysts follow a benign course, a small but significant number are either malignant at the time of diagnosis or have the potential to develop into pancreatic cancer during a patient's lifetime.

MOVANTIK tablets get FDA approval for treatment of OIC in patients with chronic, non-cancer pain

Nektar Therapeutics reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain.

Read more Medical News

› Verified 3 days ago